MPO and periodontal disorder: Treatment with Carvedilol (10 mg/kg) significantly reduced MPO activity (p<0.05), however, GSH levels were unaltered when compared to GSH levels in rats presenting with periodontal disease and treated with vehicle (Figure 3).